This webinar will demonstrate the use of the Corning Matribot Bioprinter to accurately and consistently dispense pancreatic cancer organoids for drug testing.

Our presenter, Hilary Sherman, Senior Scientist at Corning Life Sciences, will also review:

  • Assessing dispensed organoid cultures for toxicity to several chemotherapeutics that are traditionally used for treating pancreatic cancer
  • Data that demonstrates an automated way to screen for the best drug choice for an individual’s pancreatic cancer
  • New benchtop bioprinter cooling syringe printhead technology that enables you to biodispense 3D droplets or droplet arrays for organoid applications

September 8, 17:00 h

REGISTER NOW FOR FREE